These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7252332)

  • 61. Neutrophil and monocyte chemotaxis in acutely infected patients with cystic fibrosis.
    Church JA; Keens TG; Wang CI
    Ann Allergy; 1980 Oct; 45(4):217-9. PubMed ID: 7425391
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neutrophil functions in rheumatoid arthritis.
    Nada R; Datta U; Deodhar SD; Sehgal S
    Indian J Pathol Microbiol; 1999 Jul; 42(3):283-9. PubMed ID: 10862285
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
    Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
    J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chemotactic effect of melatonin on leukocytes.
    Peña C; Rincon J; Pedreanez A; Viera N; Mosquera J
    J Pineal Res; 2007 Oct; 43(3):263-9. PubMed ID: 17803523
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Helicobacter pylori products upregulate neutrophil superoxide anion production.
    Tennenberg SD; Dekhne N; Gordon D; Weller J; McCurdy B; Lange P; Kozol RA
    Int J Surg Investig; 1999; 1(4):301-6. PubMed ID: 12774453
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes.
    Kownatzki E; Kapp A; Uhrich S
    Clin Exp Immunol; 1986 Apr; 64(1):214-22. PubMed ID: 3731527
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Structural requirements for the activity of an immunologically generated lipid chemotactic factor.
    Valone FH; Goetzl EJ
    Immunology; 1980 Nov; 41(3):517-24. PubMed ID: 6780447
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inflammatory proteins: chemical and biological aspects.
    Ward PA
    Clin Biochem; 1980 Oct; 13(5):187-90. PubMed ID: 7006854
    [No Abstract]   [Full Text] [Related]  

  • 69. Leucocyte chemotactic activity in the parallel bioassay of guinea--pig lymphokines.
    DeFranco MF; Hanson JM; Morley J; Wolstencroft RA; Dumonde DC
    Immunology; 1977 Feb; 32(2):179-90. PubMed ID: 844893
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of chemotactic factor inactivation - a fetal lamb model.
    Tannous R; Kisker CT; Clarke WR
    Pediatr Res; 1982 Jul; 16(7):538-42. PubMed ID: 7110774
    [No Abstract]   [Full Text] [Related]  

  • 71. Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries.
    Miller AP; Feng W; Xing D; Weathington NM; Blalock JE; Chen YF; Oparil S
    Circulation; 2004 Sep; 110(12):1664-9. PubMed ID: 15353495
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Leukotriene B4 and neutrophil-derived eosinophil chemotactic factor: comparison of their biological activities.
    Czarnetzki BM; Frosch PJ; Mardin M; Macher E
    Monogr Allergy; 1983; 18():193-5. PubMed ID: 6316127
    [No Abstract]   [Full Text] [Related]  

  • 73. Asymmetrical protein kinase A activity establishes neutrophil cytoskeletal polarity and enables chemotaxis.
    Jones SL; Sharief Y
    J Leukoc Biol; 2005 Jul; 78(1):248-58. PubMed ID: 15817703
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Natural inhibitors of leukotaxis.
    Ward PA
    Prog Clin Biol Res; 1977; 13():77-81. PubMed ID: 400762
    [No Abstract]   [Full Text] [Related]  

  • 75. Inhibition of neutrophil chemotaxis in association with experimental angioedema in patients with cold urticaria: a model of chemotactic deactivation in vivo.
    Center DM; Soter NA; Wasserman SI; Austen KF
    Clin Exp Immunol; 1979 Jan; 35(1):112-8. PubMed ID: 428142
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chemotactic factors associated with leukocyte emigration in immune tissue injury: their separation, characterization, and functional specificity.
    Hayashi H; Honda M; Shimokawa Y; Hirashima M
    Int Rev Cytol; 1984; 89():179-250. PubMed ID: 6381365
    [No Abstract]   [Full Text] [Related]  

  • 77. Ontogeny of neutrophil chemotaxis in fetal lambs.
    Raghunathan R; Faust J; Misra S; Miller ME
    Pediatr Res; 1986 Mar; 20(3):265-8. PubMed ID: 3703615
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Partial analysis and purification of polymorphonuclear neutrophil chemotactic inhibitors in serum from anergic patients.
    Christou NV; Meakins JL
    Arch Surg; 1983 Feb; 118(2):156-60. PubMed ID: 6849633
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity.
    Schröder JM; Mrowietz U; Christophers E
    J Immunol; 1988 May; 140(10):3534-40. PubMed ID: 3283239
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of a neutrophil chemotactic inhibitor in a patient with recurrent pyoderma.
    Robinson LD; Wooten SK; Kelly AP
    Arch Dermatol; 1979 Apr; 115(4):453-7. PubMed ID: 434868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.